Nina Rautio1, Jari Jokelainen2, Heikki Oksa3, Timo Saaristo3, Leena Moilanen4, Mauno Vanhala5, Markku Peltonen6, Eeva Korpi-Hyövälti7, Jaakko Tuomilehto8, Matti Uusitupa9, Markku Timonen10, Sirkka Keinänen-Kiukaanniemi2. 1. Pirkanmaa Hospital District, Tampere, Finland. Electronic address: nina.rautio@oulu.fi. 2. Faculty of Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; Unit of General Practice, Oulu University Hospital, Oulu, Finland. 3. Pirkanmaa Hospital District, Tampere, Finland. 4. Department of Medicine, Kuopio University Hospital, Kuopio, Finland. 5. Unit of Family Practice, Central Finland Health Care District, Jyväskylä, Finland. 6. National Institute for Health and Welfare, Helsinki, Finland. 7. Department of Internal Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland. 8. Center for Vascular Prevention, Danube-University Krems, Krems, Austria. 9. Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland; Research Unit, Kuopio University Hospital, Kuopio, Finland. 10. Faculty of Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.
Abstract
AIM: To examine whether depressive symptoms are associated with the effectiveness of lifestyle counseling on cardio-metabolic risk profile and glucose homeostasis during one-year follow-up in individuals at high risk for type 2 diabetes (T2D). METHODS: A total of 10,149 individuals took part in the implementation project of the national diabetes prevention program (FIN-D2D) conducted in primary health care setting in Finland. At baseline, altogether 2798 non-diabetic individuals participated in the one-year follow-up, and 2275 of them had at least one group or individual counseling visit. RESULTS: 4.0% of the individuals (n=78) had depressive symptoms, while 96.0% (n=1889) were free of depressive symptoms at baseline. Individuals who had depressive symptoms had higher body mass index and waist circumference at baseline than individuals without depressive symptoms. In terms of changes in cardio-metabolic risk profile and glucose homeostasis the effectiveness of lifestyle counseling was parallel between individuals with and without depressive symptoms during the one-year follow-up. CONCLUSIONS: Effectiveness of lifestyle counseling did not differ between individuals with and without depressive symptoms. Individuals with depressive symptoms should not be excluded from lifestyle intervention programs.
AIM: To examine whether depressive symptoms are associated with the effectiveness of lifestyle counseling on cardio-metabolic risk profile and glucose homeostasis during one-year follow-up in individuals at high risk for type 2 diabetes (T2D). METHODS: A total of 10,149 individuals took part in the implementation project of the national diabetes prevention program (FIN-D2D) conducted in primary health care setting in Finland. At baseline, altogether 2798 non-diabetic individuals participated in the one-year follow-up, and 2275 of them had at least one group or individual counseling visit. RESULTS: 4.0% of the individuals (n=78) had depressive symptoms, while 96.0% (n=1889) were free of depressive symptoms at baseline. Individuals who had depressive symptoms had higher body mass index and waist circumference at baseline than individuals without depressive symptoms. In terms of changes in cardio-metabolic risk profile and glucose homeostasis the effectiveness of lifestyle counseling was parallel between individuals with and without depressive symptoms during the one-year follow-up. CONCLUSIONS: Effectiveness of lifestyle counseling did not differ between individuals with and without depressive symptoms. Individuals with depressive symptoms should not be excluded from lifestyle intervention programs.
Authors: Ethan M Balk; Amy Earley; Gowri Raman; Esther A Avendano; Anastassios G Pittas; Patrick L Remington Journal: Ann Intern Med Date: 2015-09-15 Impact factor: 25.391
Authors: Anne Jølle; Bjørn Olav Åsvold; Jostein Holmen; Sven Magnus Carlsen; Jaakko Tuomilehto; Johan Håkon Bjørngaard; Kristian Midthjell Journal: BMJ Open Diabetes Res Care Date: 2018-05-09